Cargando…
Natural antiviral compound silvestrol modulates human monocyte‐derived macrophages and dendritic cells
Outbreaks of infections with viruses like Sars‐CoV‐2, Ebola virus and Zika virus lead to major global health and economic problems because of limited treatment options. Therefore, new antiviral drug candidates are urgently needed. The promising new antiviral drug candidate silvestrol effectively inh...
Autores principales: | Blum, Leonard, Geisslinger, Gerd, Parnham, Michael J., Grünweller, Arnold, Schiffmann, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267175/ https://www.ncbi.nlm.nih.gov/pubmed/32374474 http://dx.doi.org/10.1111/jcmm.15360 |
Ejemplares similares
-
In Vitro Safety, Off-Target and Bioavailability Profile of the Antiviral Compound Silvestrol
por: Schiffmann, Susanne, et al.
Publicado: (2022) -
Inhibition of Hepatitis E Virus Spread by the Natural Compound Silvestrol
por: Glitscher, Mirco, et al.
Publicado: (2018) -
Silvestrol Inhibits Chikungunya Virus Replication
por: Henss, Lisa, et al.
Publicado: (2018) -
Inhibition of Zika Virus Replication by Silvestrol
por: Elgner, Fabian, et al.
Publicado: (2018) -
Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses
por: Müller, Christin, et al.
Publicado: (2018)